Bringing safe and effective cell therapies to the bedside

Article Abstract:

New rules to assess the safety and efficacy of human cell- and tissue-based products are the culmination of a multiyear, cooperative effort between the US government and the biotech industry. The Food and Drug Administration (FDA) new regulation strikes the right balance between safety and encouragement of the development of new experimental medicines for unmet needs.

Science & research, Research, United States. Food and Drug Administration, Cellular therapy, Cell therapy

---

Industry warily eyes new Medicare drug plan

Article Abstract:

A new subsection of Medicare, known as Part D, was launched under intense scrutiny on 1 January 2006. The regulations authored by the Centers for Medicaid and Medicare Service provide a roughly 3,000 Part D drug plans wide leeway in setting prices while each plan individually negotiates wholesale prices with manufacturers.

Government domestic functions, Administration of Public Health Programs, Health Care Financing Admin, United States. Centers for Medicare and Medicaid Services, Health policy, Medicare Part D

---

Hedge funds gain edge by doubling biotech investment

Article Abstract:

Hedge funds have doubled their investment in biotech. Hedge funds have become increasingly popular with investors because it can use investment techniques not available to mutual funds that allow increased returns on investment while mitigating risks associated with biotech.

Sales & consumption, Financial management, Management investment, open-end, Company investment, Investments, Mutual fund industry, Hedge funds, Market size

Similar abstracts:

• Abstracts: Proactive accounting: a key factor in the success of biotechnology startups. Strategic HR for today's biotechnology companies
• Abstracts: Andrea Wrinkle Release Skin Care Products. Avon Healthy Remedies Irritated Skin Treatment
• Abstracts: Oriville Redenbacher's Organic Microwave Popcorn. Butterball Extra Thin Sliced turkey Breast Lunchmeat
• Abstracts: Guayaki Yerba Mate Latte Concentrate; Mate Chai Latte. Pixie Mate Yerba Teas
• Abstracts: China beckons to clinical trial sponsor. Chinese manufacturers vie for piece of outsourcing pie. China kickstart its vaccine market

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.